MedPath

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

Not Applicable
Not yet recruiting
Conditions
Peripheral Artery Disease
Coronary Artery Disease
Interventions
Diagnostic Test: Coronary computed topography (CT) angiography with FFR-CT
Registration Number
NCT06387355
Lead Sponsor
VA Office of Research and Development
Brief Summary

Peripheral artery disease, lack or blood flow to the legs, has a high prevalence in the Veteran population. In patients with severe peripheral artery disease that requires an endovascular or surgical intervention for lower leg revascularization, the long-term mortality of approximately 50% is worse that most cancers. The goal of this study is to develop a management strategy to improve cardiovascular outcomes in this high-risk peripheral artery disease population after lower extremity revascularization.

Detailed Description

This study will be to conduct a randomized, controlled, multi-center clinical trial to evaluate a non-invasive management strategy of a computed topography (CT) scan of the coronary arteries and computational analysis of coronary perfusion with selective coronary revascularization plus optimal medical therapy compared to optimal medical therapy. Therefore, this study will provide the opportunity for Veterans to participate in a clinical trial to reduce the very high cardiac-related mortality rate in this population.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
450
Inclusion Criteria
  • Male or female 50 to 85
  • Severe intermittent claudication with ABI < 0.6 or monophasic waveform if non-compressible and TBI < 0.6
  • Chronic limb threatening ischemia (CLTI) with pain at rest (Rutherford Category 4) with ABI < 0.5 or TBI < 0.6
  • CLTI with minor tissue loss (Rutherford Category 5) with ABI < 0.5 or TBI < 0.6
  • Completed Lower Extremity Revascularization and enrolled within 45 days
  • The patient or legal representative will provide informed written consent
  • The patient has a life expectancy of at least 1 year
Exclusion Criteria
  • Major tissue loss of the ischemic limb (Rutherford Category 6)
  • Uncompensated congestive heart failure (NYHA class IV)
  • Myocardial infarction or stroke within the past 90 days
  • Prior coronary artery bypass graft (CABG) revascularization surgery
  • Prior percutaneous coronary intervention (PCI) with angioplasty or stenting
  • Presence of a pacemaker
  • Congestive heart failure with Ejection Fraction < 30%
  • Elevated liver function tests more than twice the upper limit of normal
  • Severe Chronic renal disease (Glomerular Filtration Rate, GFR < 30) or on hemodialysis
  • Pregnancy, Human Immunodeficiency Virus, or organ transplant recipients
  • Current malignancy or malignancy within the last two years unless the treating oncologic physician provides prognosis of an anticipated 2- year survival (i.e., adequately treated non-melanoma skin cancer or adequately treated prostate cancer without metastatic disease)
  • Any condition the review panel determines would make the patient unsuitable for participation in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Investigational Treatment StrategyCoronary computed topography (CT) angiography with FFR-CTThis arm will have a coronary CTA with FFR-CT with selective coronary artery revascularization plus optimal medical therapy after lower extremity revascularization
Primary Outcome Measures
NameTimeMethod
Major adverse cardiovascular events (MACE)2 years

cardiovascular-related death or myocardial infarction

Secondary Outcome Measures
NameTimeMethod
Amputation-free survival2 years

freedom from major amputation

Myocardioal infarction2 years

heart attack

All-cause mortality2 years

death related to any cause

Cardiovascular-related death2 years

death related to cardiovascular disease (i.e., heart attack)

Trial Locations

Locations (7)

Louis Stokes VA Medical Center, Cleveland, OH

🇺🇸

Cleveland, Ohio, United States

VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

🇺🇸

Pittsburgh, Pennsylvania, United States

VA Puget Sound Health Care System Seattle Division, Seattle, WA

🇺🇸

Seattle, Washington, United States

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

🇺🇸

Dallas, Texas, United States

Rocky Mountain Regional VA Medical Center, Aurora, CO

🇺🇸

Aurora, Colorado, United States

North Florida/South Georgia Veterans Health System, Gainesville, FL

🇺🇸

Gainesville, Florida, United States

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath